MedTrace Logo

Open-label Study to Assess Increasing Levels of NAD+(Nicotinamide Adenine Dinucleotide)

NCT03707652 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2018-10-18

No results posted yet for this study

Summary

The purpose of this study is to assess an effective single oral supplement or combination of oral supplements for increasing whole blood NAD+ levels.

Conditions

  • Increase in Blood Levels of Nicotinamide Adenine Dinucleotide (NAD+)

Interventions

DIETARY_SUPPLEMENT

Oral supplement A

1, 2 or 4 capsules daily of oral supplement A for 3 days

DIETARY_SUPPLEMENT

Oral supplement B

4 capsules daily of oral supplement B for 3 days

DIETARY_SUPPLEMENT

Oral supplement C

1,2 or 4 capsules daily of oral supplement C for 3 days

DIETARY_SUPPLEMENT

Oral supplement D

1 or 2 tablets daily of oral supplement D for 3 days

DIETARY_SUPPLEMENT

Oral Supplement D in combination with oral supplement C

1 or 2 tablets of oral supplement D in combination with 2 or 4 capsules of oral supplement C for 3 days

Sponsors & Collaborators

  • Supplement Formulators, Inc.

    lead INDUSTRY

Principal Investigators

  • Andrew Swick, Ph.D · LIfe Extension

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-12
Primary Completion
2018-05-16
Completion
2018-05-24

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03707652 on ClinicalTrials.gov